SHANGHAI, Aug. 28, 2026 /PRNewswire/ -- Asieris Pharmaceuticals today released its 2026 Semi-Annual Report, showing comprehensive progress across all business segments. With the gradual realization of commercial launch and international expansion for its core products, the company is accelerating its transition from Biotech to Biopharma: CEVIRA®, the world's first...
BANGKOK, Feb. 13, 2025 /PRNewswire/ -- During a meeting with Thailand's Prime Minister, Ms. Paetongtarn Shinawatra, in Bangkok today, Mr. Masahiro Moro, President and CEO...
JAKARTA, Indonesia, Feb. 13, 2025 /PRNewswire/ -- PT Bank Rakyat Indonesia (Persero) Tbk (IDX: BBRI) continues to demonstrate resilience amid economic challenges, recording a...